Nuvectis Pharma Up 97%, Insider Buyers Are Up 344%
Click to view quick news summary (Spoiler)
Insiders at Nuvectis Pharma are seeing a 344% return on their investments as the company's stock skyrocketed 97% recently. With insiders retaining 42% ownership, market sentiment remains optimistic about the biotech's long-term growth.
Nuvectis Pharma, Inc. insiders who bought shares over the past year were rewarded handsomely last week.The stock rose 97%, resulting in a US$355m rise in the company's market capitalisation, translating to a gain of 344% on their initial investment.As a result, their original purchase of US$1.13m worth of stock is now worth US$5.00m.While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
The Last 12 Months Of Insider Transactions At Nuvectis Pharma
Over the last year, we can see that the biggest insider purchase was by insider Charles Mosseri-Marlio for US$957k worth of shares, at about US$6.28 per share.Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$27.19.Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.
In the last twelve months Nuvectis Pharma insiders were buying shares, but not selling.Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term.Nuvectis Pharma insiders own 42% of the company, currently worth about US$306m based on the recent share price.
So What Does This Data Suggest About Nuvectis Pharma Insiders?
It doesn't really mean much that no insider has traded Nuvectis Pharma shares in the last quarter.On a brighter note, the transactions over the last year are encouraging.It would be great to see more insider buying, but overall it seems like Nuvectis Pharma insiders are reasonably well aligned (owning significant chunk of the company's shares) and optimistic for the future.
While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision.Our analysis shows 3 warning signs for Nuvectis Pharma (1 is significant!) and we strongly recommend you look at these before investing.
